FINAL 5/1/2024 Financial Supplement First Quarter 2024 This document is a statistical supplement to Aflac's quarterly earnings release. Throughout the presentation, amounts presented may not foot due to rounding. As you review the supplement, please note the non-U.S. GAAP financial measures and definitions found at the back of this document. The Company adopted the Financial Accounting Standards Board's Accounting Standard Update 2018-12 Financial Services - Insurance: Targeted Improvements to the Accountin ...

All investors love getting big returns from their portfolio, whether it's through stocks, bonds, ETFs, or other types of securities. But when you're an income investor, your primary focus is generating consistent cash flow from each of your liquid investments.Cash flow can come from bond interest, interest from other types of investments, and of course, dividends. A dividend is that coveted distribution of a company's earnings paid out to shareholders, and investors often view it by its dividend yield, a me ...

Investors are always looking for stocks that are poised to beat at earnings season and Aflac Incorporated (AFL) may be one such company. The firm has earnings coming up pretty soon, and events are shaping up quite nicely for their report.That is because Aflac is seeing favorable earnings estimate revision activity as of late, which is generally a precursor to an earnings beat. After all, analysts raising estimates right before earnings — with the most up-to-date information possible — is a pretty good indic ...

Aflac Incorporated (AFL) is scheduled to release first-quarter 2024 results on May 1, 2024, after the closing bell. Net premiums earned derived from growing cancer insurance sales coupled with cost-cutting initiatives, partly offset by the impact of paid-up policies, are expected to shape its quarterly results.Q1 EstimatesThe Zacks Consensus Estimate for Aflac’s first-quarter earnings per share is pegged at $1.58, which implies a 1.9% rise from the year-ago quarter’s reported figure.The consensus mark for r ...

Wall Street analysts forecast that Aflac (AFL) will report quarterly earnings of $1.58 per share in its upcoming release, pointing to a year-over-year increase of 1.9%. It is anticipated that revenues will amount to $4.32 billion, exhibiting a decline of 10.1% compared to the year-ago quarter.The consensus EPS estimate for the quarter has undergone an upward revision of 0.1% in the past 30 days, bringing it to its present level. This represents how the covering analysts, as a whole, have reassessed their in ...

The Zacks Accident and Health Insurance industry is expected to ride on the increase in underwriting exposure. Aflac (AFL) , Unum Group (UNM) , Employers Holdings (EIG) , AMERISAFE (AMSF) and Trupanion (TRUP) should continue to benefit from prudent underwriting standards. However, a rise in claims frequency could weigh on the positives.The industry has been witnessing soft pricing over the past several quarters, which is not expected to change any time soon. Nonetheless, a rise in claims, with business acti ...

COLUMBUS, Ga., April 18, 2024 /PRNewswire/ -- Aflac Incorporated (NYSE: AFL) announced today that it has revised the time of its first quarter webcast teleconference call on Thursday, May 2, 2024 to 7:00 a.m. (ET), which is one hour earlier than the originally scheduled 8:00 a.m. start time, to avoid timing conflicts with other industry webcasts. During the 7:00 a.m. (ET) webcast on Thursday, May 2, as planned, Aflac Incorporated Chairman, Chief Executive Officer and President Daniel P. Amos, along with Exe ...

This company trades at a dirt-cheap valuation and is making strides after a difficult stretch.The stock market is on a great run, with the S&P 500 trading around all-time highs and up 53% since the bull market began in October 2022.However, it hasn't been smooth sailing for all stocks. Lincoln National Corporation (LNC -1.97%) is one beaten-down dividend stock selling at a bargain-bin price. Although the stock is up 48% in the last year, it remains 55% below its all-time high price as the company progresses ...

Core Viewpoint - Aflac remains a strong dividend growth company despite recent stock price underperformance compared to the S&P 500, with a total return of approximately 6% since December 2023, compared to the S&P's nearly 10% [2] - The company is expected to benefit from increasing cancer insurance sales due to rising cancer prevalence among younger adults in both the Japanese and US markets, which is seen as a long-term growth catalyst [4][5] Company Overview - Aflac specializes in life insurance and health supplemental products, operating primarily in two segments: Aflac Japan and Aflac US, offering services such as illness insurance, wellness care, nursing care, and life insurance [4] - The company has increased its dividend payout for 41 consecutive years, positioning it close to the Dividend Kings list, with a strong focus on dividend growth rather than yield [4][11] Financial Performance - In Q4, Aflac reported revenue of $3.8 billion and EPS of $1.25, missing analyst expectations of $4.4 billion in revenue and $1.45 EPS [5] - Total revenues for 2023 were $18.7 billion, reflecting a slight 2.3% decrease from the previous year, while pretax earnings reached an all-time high of $1.5 billion, a 10.4% increase year-over-year [6] - The Japan segment saw a 10.9% increase in total sales, driven by a 26% rise in cancer insurance sales, while the US segment experienced a 5% sales increase, with cancer insurance sales up nearly 25% [5][6] Market Position and Growth Potential - Aflac holds a market share nearly three times greater than its nearest competitor, with a total market share of 29% globally [7][8] - The company aims for net premium growth of 3-5% in fiscal year 2024, supported by strategies to reduce expenses and increase margins [8] - Management forecasts sales in Japan to reach ¥67 billion to ¥73 billion by the end of 2026, emphasizing the importance of acquiring a younger customer base [5][8] Dividend Analysis - The current dividend yield is 2.3%, with a quarterly payout of $0.50 per share, and a low payout ratio of approximately 28%, indicating room for continued dividend growth [11][13] - The dividend has grown at an average rate of 13% per year since 2019, with an estimated price target of $100 per share based on a dividend discount model [9][10] Strategic Focus - Aflac is focusing on acquiring a younger customer base to drive future growth in cancer insurance sales, which is expected to rise significantly due to increasing cancer rates [5][17] - The company is also working to optimize its distribution channels to enhance financial protection for consumers [5]

LOS ANGELES, March 19, 2024 /PRNewswire/ -- TOGETHXR, the trailblazing media and commerce company co-founded by sports media veteran Jessica Robertson alongside world-renowned professional athletes Alex Morgan, Chloe Kim, Simone Manuel, and Sue Bird, is proud to announce a dynamic year-long partnership with Aflac, a leading provider of supplemental health insurance in the U.S. The partnership, created in collaboration with Aflac's media agency, Spark Foundry, launches this month when the two present a serie ...